Home Cart Sign in  
Chemical Structure| 319460-85-0 Chemical Structure| 319460-85-0

Structure of Axitinib
CAS No.: 319460-85-0

Chemical Structure| 319460-85-0

Axitinib

CAS No.: 319460-85-0

Axitinib emerges as a multi-targeted tyrosine kinase inhibitor with IC50 values of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, and PDGFRβ, respectively.

Synonyms: AG-013736

4.5 *For Research Use Only !

Cat. No.: A226761 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇ˶ÊÊ Inquiry Inquiry
50mg łËó¶ÊÊ Inquiry Inquiry
100mg łÍ§¶ÊÊ Inquiry Inquiry
250mg łďʶÊÊ Inquiry Inquiry
1g łÇóÿ¶ÊÊ Inquiry Inquiry
5g łòóò¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 1mg

    łÇ˶ÊÊ

  • 50mg

    łËó¶ÊÊ

  • 100mg

    łÍ§¶ÊÊ

  • 250mg

    łďʶÊÊ

  • 1g

    łÇóÿ¶ÊÊ

  • 5g

    łòóò¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Axitinib

CAS No. :319460-85-0
Formula : C22H18N4OS
M.W : 386.47
SMILES Code : O=C(NC)C1=CC=CC=C1SC2=CC3=C(C=C2)C(/C=C/C4=NC=CC=C4)=NN3
Synonyms :
AG-013736
MDL No. :MFCD09837898
InChI Key :RITAVMQDGBJQJZ-FMIVXFBMSA-N
Pubchem ID :6450551

Safety of Axitinib

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P501-P273-P260-P270-P264-P280-P391-P314-P337+P313-P305+P351+P338-P301+P312+P330
Class:9
UN#:3077
Packing Group:

Related Pathways of Axitinib

RTK

Isoform Comparison

Biological Activity

Target
  • VEGFR1

    VEGFR1/FLT1, IC50:0.1 nM

  • VEGFR3

    VEGFR3, IC50:0.1 nM-0.3 nM

  • VEGFR2

    VEGFR2/KDR, IC50:0.2 nM

    VEGFR2/Flk1, IC50:0.18 nM

  • PDGFRβ

    PDGFRβ, IC50:1.6 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
human liver microsomes (HLMs) 100 μM 40 minutes Axitinib significantly inhibited buspirone hydroxylation and N-dealkylation, with an inhibition rate of over 85%. PMC9252588
rat liver microsomes (RLMs) 100 μM 40 minutes Axitinib significantly inhibited buspirone hydroxylation and N-dealkylation, with an inhibition rate of over 85%. PMC9252588
786-0 cells 1 μM and 5 μM 48 hours Axitinib increased the secretion of extracellular vesicles (EVs) from 786-0 cells in a dose-dependent manner. PMC8642495
A498 cells 1 μM and 5 μM 48 hours Axitinib increased the secretion of extracellular vesicles (EVs) from A498 cells without affecting cell viability or the size distribution of the vesicles. PMC8642495
bEnd.3 cells 0-10 μg/ml 24 hours To evaluate the effect of Axitinib on pathological BBB restoration, results showed that Axitinib at non-cytotoxic doses effectively restored BBB function PMC8841308
U87 MG cells 0-10 μg/ml 24 hours To evaluate the effect of Axitinib on pathological BBB restoration, results showed that Axitinib at non-cytotoxic doses effectively restored BBB function PMC8841308

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Orthotopic GBM mouse model Intravenous injection 10 mg/kg 7 consecutive days To evaluate the therapeutic effect of Axitinib on GBM, results showed that Axitinib significantly prolonged the median survival time of GBM mice PMC8841308

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00692341 Hepatic Insufficiency Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site Orlando, Florida, United States, 32809 Less <<
NCT03386929 Non-small Cell Lung Cancer Met... More >>astatic Non-Small Cell Lung Cancer Stage IIIB Less << Phase 1 Phase 2 Recruiting December 2022 United States, California ... More >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Sarah MOORE       sam055@ucsd.edu    Principal Investigator: Lyudmila BAZHENOVA, MD          United States, South Dakota Avera Cancer Center Recruiting Sioux Falls, South Dakota, United States, 57105 Contact: Martha LANG       Martha.lang@avera.org    Principal Investigator: Benjamin SOLOMON, MD          France Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Séverine LAURENT       severine.laurent@lyon.unicancer.fr    Principal Investigator: Pierre SAINTIGNY, MD          Israel Chiam Sheba Medical Center Recruiting Ramat Gan, Israel, 5265601 Contact: Yona GILADY       yona.gilady@sheba.health.gov.il    Principal Investigator: Jair BAR, MD          Luxembourg Centre Hospitalier Luxembourg Recruiting Luxembourg, Luxembourg, 1210 Contact: Lucile PERNOT       lucile.pernot@lih.lu    Principal Investigator: Guy BERCHEM, MD          Spain Vall Hebron Institute of Oncology Recruiting Barcelona, Spain, 08035 Contact: LLuisa CARBONELL       llcarbonell@vhio.net    Principal Investigator: Enriqueta Felip, MD Less <<
NCT00389441 Thyroid Neoplasms PHASE2 COMPLETED 2025-09-12 Pfizer Investigational Site, O... More >>range, California, 92868, United States|Pfizer Investigational Site, Aurora, Colorado, 80010, United States|Pfizer Investigational Site, Tampa, Florida, 33612, United States|Pfizer Investigational Site, Chicago, Illinois, 60637-1470, United States|Pfizer Investigational Site, Wichita, Kansas, 67226, United States|Pfizer Investigational Site, Witchita, Kansas, 67220, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Buffalo, New York, 14263, United States|Pfizer Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|Pfizer Investigational Site, London, Ontario, N6A 4L6, Canada|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Nanjing, Jiangsu, 210002, China|Pfizer Investigational Site, Beijing, 100021, China|Pfizer Investigational Site, Shanghai, 20001/200127, China|Pfizer Investigational Site, Shanghai, 200233, China|Pfizer Investigational Site, Praha 5, 150 06, Czech Republic|Pfizer Investigational Site, Vellore, Tamil Nadu, 632 004, India|Pfizer Investigational Site, Milano, 20133, Italy|Pfizer Investigational Site, Pisa, 56124, Italy|Pfizer Investigational Site, Gliwice, 44-101, Poland|Pfizer Investigational Site, Warszawa, 02-781, Poland|Pfizer Investigational Site, Pamplona, Navarra, 31008, Spain|Pfizer Investigational Site, Madrid, 28033, Spain|Pfizer Investigational Site, Glasgow, G12 0YN, United Kingdom Less <<
NCT00460603 Colorectal Neoplasms Phase 1 Phase 2 Completed - -
NCT01469052 Advanced Solid Tumors Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT00692341 - Completed - -
NCT01469052 - Completed - -
NCT02184416 - Recruiting July 20, 2019 -
NCT00389441 Thyroid Neoplasms PHASE2 COMPLETED 2025-09-12 Pfizer Investigational Site, O... More >>range, California, 92868, United States|Pfizer Investigational Site, Aurora, Colorado, 80010, United States|Pfizer Investigational Site, Tampa, Florida, 33612, United States|Pfizer Investigational Site, Chicago, Illinois, 60637-1470, United States|Pfizer Investigational Site, Wichita, Kansas, 67226, United States|Pfizer Investigational Site, Witchita, Kansas, 67220, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Buffalo, New York, 14263, United States|Pfizer Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|Pfizer Investigational Site, London, Ontario, N6A 4L6, Canada|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Nanjing, Jiangsu, 210002, China|Pfizer Investigational Site, Beijing, 100021, China|Pfizer Investigational Site, Shanghai, 20001/200127, China|Pfizer Investigational Site, Shanghai, 200233, China|Pfizer Investigational Site, Praha 5, 150 06, Czech Republic|Pfizer Investigational Site, Vellore, Tamil Nadu, 632 004, India|Pfizer Investigational Site, Milano, 20133, Italy|Pfizer Investigational Site, Pisa, 56124, Italy|Pfizer Investigational Site, Gliwice, 44-101, Poland|Pfizer Investigational Site, Warszawa, 02-781, Poland|Pfizer Investigational Site, Pamplona, Navarra, 31008, Spain|Pfizer Investigational Site, Madrid, 28033, Spain|Pfizer Investigational Site, Glasgow, G12 0YN, United Kingdom Less <<
NCT00460603 - Completed - -
NCT00600821 Non-Small-Cell Lung Carcinoma ... More >> Adenocarcinoma Less << Phase 2 Completed - -
NCT00094055 Thyroid Neoplasms Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Colorado Pfizer Investigational Site Aurora, Colorado, United States, 80010 Pfizer Investigational Site Denver, Colorado, United States, 80220 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21231-1000 Pfizer Investigational Site Baltimore, Maryland, United States, 51231 United States, Michigan Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 Less <<
NCT00094055 - Completed - -
NCT00726752 Neoplasms Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kobe-shi, Hyogo-ken, Japan Less <<
NCT01020136 Healthy Volunteer Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00726752 - Completed - -
NCT03086174 Kidney Cancer Stage Iv ... More >> Advanced Melanoma Less << Phase 1 Recruiting February 2021 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Guo, Phd; Md       guoj307@126.com    Principal Investigator: Jun Guo, PhD; MD          Sub-Investigator: xinan Sheng, MD Less <<
NCT00094107 Melanoma Skin... More >> Neoplasms Less << Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Miami Beach, Florida, United States, 33140 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Pennsylvania Pfizer Investigational Site Clairton, Pennsylvania, United States, 15025 Pfizer Investigational Site Greensburg, Pennsylvania, United States, 15601 Pfizer Investigational Site Johnstown, Pennsylvania, United States, 15901 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15232-1305 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15232 Pfizer Investigational Site Wexford, Pennsylvania, United States, 15090 France Pfizer Investigational Site Paris Cedex 13, France, 75651 Less <<
NCT00600821 - Completed - -
NCT00094107 - Completed - -
NCT00219557 Pancreatic Neoplasms Phase 2 Completed - -
NCT00918632 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1070 Less <<
NCT00071006 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Texas ... More >> Pfizer Investigational Site Houston, Texas, United States, 77030 Less <<
NCT03538717 - Recruiting June 30, 2019 Spain ... More >> Hospital Duran i Reynals Not yet recruiting Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Universitario Parc Taulí Not yet recruiting Sabadell, Barcelona, Spain, 08208 Hospital Sant Pau i Santa Tecla Not yet recruiting Tarragona, Barcelona, Spain, 43003 Hospital Universitario Mutua Terrassa Not yet recruiting Terrassa, Barcelona, Spain, 08221 Complejo Hospitalario la Mancha Centro Not yet recruiting Alcazar de San Juan, Ciudad REAL, Spain, 13600 Hospital Universitario Principe de Asturias Not yet recruiting Alcalá de Henares, Madrid, Spain, 28805 Hospital Universitario Fundacion Alcorcón Recruiting Alcorcón, Madrid, Spain, 28922 Hospital Universitario Severo Ochoa Recruiting Leganés, Madrid, Spain, 28911 Hospital Universitario Rey Juan carlos Not yet recruiting Mostoles, Madrid, Spain, 28933 Hospital Infanta Cristina Not yet recruiting Parla, Madrid, Spain, 28981 Hospital Universitario Infanta Sofía Not yet recruiting San Sebatián De Los Reyes, Madrid, Spain, 28703 Hospital Universitario Infanta Elena Not yet recruiting Valdemoro, Madrid, Spain, 28342 Hospital Universitario Son Espases Not yet recruiting Palma de Mallorca, Mallorca, Spain, 07120 HU de Navarra, Pamplona Not yet recruiting Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias Not yet recruiting La Cuesta, Santa Cruz De Tenerife, Tenerife, Spain, 38320 Hospital Universitario Nuestra Señora de la Candelaria, Tenerife Not yet recruiting Santa Cruz de Tenerife, Tenerife, Spain, 38010 Hospita General Nuestra Señora del Prado Not yet recruiting Talavera de la Reina, Toledo, Spain, 45600 Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Hospital Universitario Vall d'Hebrón Not yet recruiting Barcelona, Spain, 08036 HU Clinic i Provincial Not yet recruiting Barcelona, Spain, 08036 Hospital Universitario Sant Pau i Santa Creu Recruiting Barcelona, Spain, 08041 Hospital General Universitario de Ciudad Real Not yet recruiting Ciudad Real, Spain, 13005 Hospital Reina Sofía Not yet recruiting Córdoba, Spain, 14004 Hospital Universitario de Cabueñes Not yet recruiting Gijón, Spain, 33394 Complejo Hospitalario de Jaén Not yet recruiting Jaén, Spain, 23007 HU De León Not yet recruiting León, Spain, 24080 Hospital Universitario Lucus Augusti (HULA_ Lugo) Not yet recruiting Lugo, Spain, 27003 Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain, 28034 Hospital Universitario Fundación Jimenez Diaz Not yet recruiting Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Hospital Universitario La Paz Not yet recruiting Madrid, Spain, 28046 Centro Integral Oncológico Clara Campal Not yet recruiting Madrid, Spain, 28050 Complejo Hospitalario Universitario de Ourense CHUOU Not yet recruiting Orense, Spain, 32005 Hospital Universitario Central de Asturias Not yet recruiting Oviedo, Spain, 33011 Hospital Universitario Santiago de Compostela Not yet recruiting Santiago de Compostela, Spain, 15076 Complejo Asistencial de Segovia Not yet recruiting Segovia, Spain, 40002 Hospita Virgen de la Salud de Toledo Not yet recruiting Toledo, Spain, 45004 Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain, 46026 Hospital Universitario de Vigo- Hospital Álvaro Cunqueiro Recruiting Vigo, Spain, 36312 H. Universitario Miguel Servet, Zaragoza Not yet recruiting Zaragoza, Spain, 50009 Hospital Clínico Uiversitario Lozano Blesa Not yet recruiting Zaragoza, Spain, 50009 Less <<
NCT01999972 Advanced Solid Tumors Phase 1 Active, not recruiting July 31, 2018 United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Indiana Investigational Drug Services IUHSCC Indianapolis, Indiana, United States, 46202 IU Health University Hospital Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Wayne State University, Dept. of Oncology Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Health Clinics and Surgery Center Minneapolis, Minnesota, United States, 55455 University of Minnesota Medical Center, Fairview IDS Pharmacy Minneapolis, Minnesota, United States, 55455 University of Minnesota Medical Center, Fairview Minneapolis, Minnesota, United States, 55455 University of Minnesota Physicians Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Utah Huntsman Cancer Hospital Salt Lake City, Utah, United States, 84112 Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 John A Moran Eye Center Salt Lake City, Utah, United States, 84132 United States, Wisconsin University Station Ophthalmology Clinic Madison, Wisconsin, United States, 53705 University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 United Kingdom St Bartholomew's Hospital - Barts Health NHS Trust London, United Kingdom, EC1A 7BE The Royal Marsden NHS Foundation Trust, Royal Marsden Hospital London, United Kingdom, SW3 6JJ Less <<
NCT00768755 Carcinoma, Non-Small Cell Lung Phase 1 Phase 2 Completed - -
NCT00219557 - Completed - -
NCT00447005 Carcinoma Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Less <<
NCT00768755 - Completed - -
NCT03172754 Renal Cell Carcinoma Phase 1 Phase 2 Recruiting April 2019 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Matthew Zibelman, MD    215-214-1515    matthew.zibelman@fccc.edu Less <<
NCT00735904 Carcinoma, Non-Small-Cell Lung... More >> (NSCLC) Less << Phase 2 Completed - Poland ... More >> Pfizer Investigational Site Torun, Poland, 87-100 Pfizer Investigational Site Wodzislaw Sl., Poland, 44-300 Romania Pfizer Investigational Site Cluj-Napoca, Cluj, Romania, 400015 Pfizer Investigational Site Bucuresti, Romania, 022328 Pfizer Investigational Site Oradea, Romania, 410032 South Africa Pfizer Investigational Site Parktown, South Africa, 2193 Ukraine Pfizer Investigational Site Dnipropetrovsk, Ukraine, 49102 Pfizer Investigational Site Donetsk, Ukraine, 83092 Pfizer Investigational Site Kyiv, Ukraine, 04107 Pfizer Investigational Site Lviv, Ukraine, 79031 Less <<
NCT00735904 - Completed - -
NCT02667886 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00071006 - Completed - -
NCT01210495 Hepatocellular Carcinoma Phase 2 Completed - -
NCT00282048 Kidney Neoplasms ... More >> Carcinoma, Renal Cell Less << Phase 2 Completed - United States, Illinois ... More >> Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, New York Pfizer Investigational Site Bronx, New York, United States, 10466 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111-2497 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT00569946 Carcinoma, Renal Cell PHASE2 COMPLETED 2012-10-30 National Cancer Center East Ho... More >>spital, Kashiwa, Chiba, 277-8577, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Tsukuba University Hospital, Tsukuba, Ibaraki, 305-8576, Japan|Iwate Medical University, Morioka, Iwate, 020-8505, Japan|Kochi Medical School Hospital, Nankoku-shi, Kochi-ken, 783-8505, Japan|Kinki University Hospital, Osakasayama, Osaka, 589-8511, Japan|Hamamatsu University School of Medicine University Hospital, Hamamatsu-City, Shizuoka, 431-3192, Japan|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|Tokyo Women's Medical University Medical Center East, Arakawa-ku, Tokyo, 116-8567, Japan|National Cancer Center, Chuo-ku, Tokyo, 104-8503, Japan|Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, 173-8610, Japan|Akita University Hospital, Akita, 010-8543, Japan|National Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Kyushu University Hospital, Department of Urology, Fukuoka, 812-8582, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan|Osaka University Hospital, Osaka, 565-0871, Japan|Tokushima University Hospotal, Tokushima, 770-8503, Japan|Yamagata University Hospital, Yamagata, 990-9585, Japan Less <<
NCT00454649 Neoplasms Phase 1 Completed - United States, Georgia ... More >> Pfizer Investigational Site Augusta, Georgia, United States, 30909 Pfizer Investigational Site Augusta, Georgia, United States, 30912 United States, Illinois Pfizer Investigational Site Harvey, Illinois, United States, 60426-4265 Pfizer Investigational Site Harvey, Illinois, United States, 60426 Pfizer Investigational Site Tinley Park, Illinois, United States, 60477 United States, Indiana Pfizer Investigational Site Hobart, Indiana, United States, 46342 Pfizer Investigational Site Munster, Indiana, United States, 46321 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 United States, Washington Pfizer Investigational Site Kennewick, Washington, United States, 99336 Poland Pfizer Investigational Site Warszawa, Poland, 02-781 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28046 Less <<
NCT00447005 - Completed - -
NCT00094094 - Completed - -
NCT00094094 Lung Neoplasms ... More >> Carcinoma, Non-small Cell Lung Less << Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Irvine, California, United States, 92612 Pfizer Investigational Site Orange, California, United States, 92868 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637 Pfizer Investigational Site Park Ridge, Illinois, United States, 60068 United States, Minnesota Pfizer Investigational Site Coon Rapids, Minnesota, United States, 55433 Pfizer Investigational Site Fridley, Minnesota, United States, 55432 Pfizer Investigational Site Robbinsdale, Minnesota, United States, 55422 United States, North Carolina Pfizer Investigational Site Charlotte, North Carolina, United States, 28203 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Germany Pfizer Investigational Site Gauting, Germany, 82131 Less <<
NCT01210495 - Completed - -
NCT00282048 - Completed - -
NCT00842244 Stomach Neoplasms ... More >> Advanced Gastric Cancer Less << Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Yufu-city, Oita, Japan Korea, Republic of Pfizer Investigational Site Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT00569946 Carcinoma, Renal Cell PHASE2 COMPLETED 2012-10-30 National Cancer Center East Ho... More >>spital, Kashiwa, Chiba, 277-8577, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Tsukuba University Hospital, Tsukuba, Ibaraki, 305-8576, Japan|Iwate Medical University, Morioka, Iwate, 020-8505, Japan|Kochi Medical School Hospital, Nankoku-shi, Kochi-ken, 783-8505, Japan|Kinki University Hospital, Osakasayama, Osaka, 589-8511, Japan|Hamamatsu University School of Medicine University Hospital, Hamamatsu-City, Shizuoka, 431-3192, Japan|Shizuoka Cancer Center, Sunto-gun, Shizuoka, 411-8777, Japan|Tokyo Women's Medical University Medical Center East, Arakawa-ku, Tokyo, 116-8567, Japan|National Cancer Center, Chuo-ku, Tokyo, 104-8503, Japan|Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, 173-8610, Japan|Akita University Hospital, Akita, 010-8543, Japan|National Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Kyushu University Hospital, Department of Urology, Fukuoka, 812-8582, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan|Osaka University Hospital, Osaka, 565-0871, Japan|Tokushima University Hospotal, Tokushima, 770-8503, Japan|Yamagata University Hospital, Yamagata, 990-9585, Japan Less <<
NCT00842244 - Completed - -
NCT01649180 Renal Cell Carcinoma PHASE2 TERMINATED 2025-03-16 Missouri Valley Cancer Consort... More >>ium, Omaha, Nebraska, 68106, United States|Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT02535533 Advanced Metastatic Clear Cell... More >> Renal Cell Carcinoma (CCRCC) Less << Phase 1 Suspended(Suspended for interi... More >>m analysis) Less << September 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT01441414 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Arizona ... More >> Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States, 85704 Arizona Oncology Associates, PC-HOPE Tucson, Arizona, United States, 85710 United States, Colorado Rocky Mountain Cancer Centers Aurora, Colorado, United States, 80012 Rocky Mountain Cancer Centers Boulder, Colorado, United States, 80303 Rocky Mountain Cancer Centers Centennial, Colorado, United States, 80112 Rocky Mountain Cancer Centers Colorado Springs, Colorado, United States, 80907 Rocky Mountain Cancer Centers Colorado Springs, Colorado, United States, 80909 Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 Rocky Mountain Cancer Centers Denver, Colorado, United States, 80220 Rocky Mountain Cancer Centers Lakewood, Colorado, United States, 80228 Rocky Mountain Cancer Centers Littleton, Colorado, United States, 80120-4413 Rocky Mountain Cancer Centers Lone Tree, Colorado, United States, 80124 Rocky Mountain Cancer Centers Longmont, Colorado, United States, 80501 Rocky Mountain Cancer Centers Parker, Colorado, United States, 80138 Rocky Mountain Cancer Centers Pueblo, Colorado, United States, 81008 Rocky Mountain Cancer Centers Thornton, Colorado, United States, 80260 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Nevada Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, North Carolina Regional Cancer Care-Durham Durham, North Carolina, United States, 27704 United States, Texas Investigational Products Center (IPC) (drug shipment only) Fort Worth, Texas, United States, 76177 Texas Oncology-Tyler Tyler, Texas, United States, 75702 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Czech Republic Masarykuv onkologicky ustav Brno, Czech Republic, 65653 Less <<
NCT01441414 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01056263 - Completed - United States, California ... More >> Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, New York Pfizer Investigational Site New York, New York, United States, 10065 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 France Pfizer Investigational Site Paris Cedex 13, France, 75651 Germany Pfizer Investigational Site Hannover, Germany, 30625 Less <<
NCT01174238 Melanoma Phase 2 Completed - United States, California ... More >> Cutaneous Onocology Group at the Helen Dillar Family Comprehensive Cancer Center UCSF San Francisco, California, United States, 94115 Less <<
NCT01056263 - Completed - -
NCT01649180 Renal Cell Carcinoma PHASE2 TERMINATED 2025-03-16 Missouri Valley Cancer Consort... More >>ium, Omaha, Nebraska, 68106, United States|Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT00454649 - Completed - -
NCT00905814 Healthy Volunteers Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT01540526 Solid Malignancies ... More >> Metastatic Castrate-resistant Prostate Cancer Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01174238 - Completed - -
NCT00920816 Kidney Neoplasms Phase 3 Active, not recruiting May 30, 2021 -
NCT01490866 - Completed - -
NCT03736330 Renal Cancer Metastatic Phase 2 Recruiting November 8, 2021 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Fang-Jian Zhou, M.D Ph.D       zhoufj@sysucc.org.cn    Contact: Zhi-Ling Zhang, M.D Ph.D       zhangzhl@sysucc.org.cn    Principal Investigator: Fang-Jian Zhou, M.D Ph.D          Principal Investigator: Jian-Chuan Xia, Ph.D          Sub-Investigator: Zhi-Ling Zhang, M.D Ph.D Less <<
NCT00828919 Solid Tumors Not Applicable Active, not recruiting May 31, 2021 -
NCT00920816 - Active, not recruiting - -
NCT00835978 Carcinoma, Renal Cell Phase 2 Completed - -
NCT01967576 Pheochromocytoma ... More >> Paraganglioma Less << Phase 2 Active, not recruiting December 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02853331 Renal Cell Carcinoma Phase 3 Active, not recruiting January 27, 2020 -
NCT01490866 Colorectal Cancer Phase 2 Completed - United States, Arkansas ... More >> NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-North St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology of SW Indiana Newburgh, Indiana, United States, 47630 Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Atlantic Health System Summit, New Jersey, United States, 07901 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Texas Health Physician Group Dallas, Texas, United States, 75243 Less <<
NCT01334073 Malignant Advanced Solid Tumor... More >>s Carcinoma, Renal Cell Less << Phase 1 Completed - France ... More >> Professeur Alain RAVAUD Bordeaux, France, 33000 Professeur Jean-Pierre DELORD Toulouse, France, 31000 Less <<
NCT00835978 - Completed - -
NCT00678392 Kidney Neoplasms Phase 3 Completed - -
NCT01385059 Stage III Prostate Cancer ... More >> Stage IV Prostate Cancer Less << Phase 2 Active, not recruiting November 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00678392 - Completed - -
NCT01352728 Hepatocellular Carcinoma PHASE2 COMPLETED 2018-06-07 Department of Clinical Oncolog... More >>y, Prince of Wales Hospital, Hong Kong, Hong Kong Less <<
NCT02133742 Renal Cell Carcinoma Phase 1 Active, not recruiting February 2019 United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Drug Shipment Address: Attn. Alicia Sammarco, RPh, NYU Investigational Pharmacy New York, New York, United States, 10016 NYU Langone Medical Center New York, New York, United States, 10016 NYU Langone New York, New York, United States, 10016 United States, Ohio Investigational Drug Services (Drug Management Only) Columbus, Ohio, United States, 43210 James Cancer Hospital Columbus, Ohio, United States, 43210 The James Cancer Hospital Columbus, Ohio, United States, 43210 Martha Morehouse Medical Plaza Columbus, Ohio, United States, 43221 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Henry-Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 Less <<
NCT00919204 Healthy Volunteers Phase 1 Completed - China ... More >> Pfizer Investigational Site Beijng, China, 100730 Less <<
NCT02636725 Alveolar Soft Part Sarcoma ... More >> Soft Tissue Sarcomas Less << Phase 2 Recruiting March 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Breelyn Wilky, MD    305-243-1287    b.wilky@med.miami.edu    Principal Investigator: Breelyn Wilky, MD          Sub-Investigator: Jonathan Trent, MD Less <<
NCT01486251 Colorectal Carcinoma Not Applicable Completed - France ... More >> Institut gustave roussy Villejuif, France, 94805 Less <<
NCT03092856 Clear Cell Renal Cell Carcinom... More >>a Metastatic Renal Cell Cancer Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 2 Recruiting July 19, 2021 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Sarmad Sadeghi, MD    323-865-0553    sarmad.sadeghi@usc.edu    Principal Investigator: Sarmad Sadeghi          University of California Davis Comprehensive Cancer Center Not yet recruiting Sacramento, California, United States, 95817 Contact: Primo N. Lara    916-734-3089       Principal Investigator: Primo N. Lara          United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Not yet recruiting Cleveland, Ohio, United States, 44195 Contact: Brian I. Rini    866-223-8100       Principal Investigator: Brian I. Rini          Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Amir Mortazavi    614-293-6196       Principal Investigator: Amir Mortazavi          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rahul A. Parikh    412-647-8073    parikhr@upmc.edu    Principal Investigator: Rahul A. Parikh Less <<
NCT02156895 Advanced Renal Cell Carcinoma COMPLETED 2021-08-06 Pfizer Tower, Seoul, 04631, Ko... More >>rea, Republic of Less <<
NCT01529138 Cancer Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01473043 Renal Cell Carcinoma NO_LONGER_AVAILABLE 2025-03-14 Pfizer Investigational Site, D... More >>ouglas, Queensland, 4814, Australia|Pfizer Investigational Site, Hobart, Tasmania, 7000, Australia|Pfizer Investigational Site, Wendouree, Victoria, 3355, Australia|Pfizer Investigational Site, Montreal, Quebec, H2X 1N8, Canada Less <<
NCT01249547 Recurrent or Metastatic NPC Phase 2 Completed - Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, Hong Kong Less <<
NCT01483638 Colorectal Carcinoma Phase 2 Terminated(The trial was prema... More >>turely closed due to lack of accrual) Less << - Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Less <<
NCT01255137 Adrenal Cortex Neoplasms PHASE2 COMPLETED 2025-12-12 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT03289533 Carcinoma, Hepatocellular Phase 1 Recruiting October 7, 2019 Japan ... More >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan, 464-8681 Iizuka Hospital Active, not recruiting Iizuka, Fukuoka, Japan, 820-8505 Kindai University Hospital, Department of Gastroenterology and Hepatology Active, not recruiting Osaka-Sayama, Osaka, Japan, 589-8511 National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Kyorin University Hospital, Department of Medical Oncology Active, not recruiting Mitaka-shi, Tokyo, Japan, 181-8611 Japanese Red Cross Musashino Hospital Active, not recruiting Musashino, Tokyo, Japan, 180-8610 National Hospital Organization Kyushu Medical Center Recruiting Fukuoka, Japan, 810-8563 Less <<
NCT01255137 Adrenal Cortex Neoplasms PHASE2 COMPLETED 2025-12-12 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT01321437 Melanoma Mali... More >>gnant Melanoma Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Less << Phase 2 Active, not recruiting December 2019 United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT03595124 Metastatic Renal Cell Carcinom... More >>a Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 TFE3 Gene Translocation TFEB Gene Translocation Less << Phase 2 Recruiting June 18, 2023 -
NCT01409200 Prostate Cancer Phase 2 Active, not recruiting February 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01508117 - Terminated(transferred study s... More >>ponsor) Less << - -
NCT01508117 Glioblastoma Multiforme Phase 2 Terminated(transferred study s... More >>ponsor) Less << - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267-0502 Less <<
NCT01727336 Advanced Renal Cell Carcinoma Phase 2 Active, not recruiting December 2018 -
NCT01744249 Neuroendocrine Tumors ... More >> Advanced Cancer Less << Phase 2 Phase 3 Recruiting October 2020 Germany ... More >> Berlin Charité Universitätsmedizin Recruiting Berlin, Germany Principal Investigator: Frank-Ulrich Pape, Dr.          Marburg Universitätsklinikum Giessen und Marburg GmbH Recruiting Marburg, Germany, 35043 Principal Investigator: Anja Rinke, Dr.          Klinikum rechts der Isar Recruiting München, Germany, 81675 Principal Investigator: Alexander Von Werder, Dr.          Italy Azienda Ospedaliera Universitaria di Perugia Recruiting Perugia, Italy, 06129 Principal Investigator: Vicenzo Minotti, Dr.          Sapienza, Universitá di Roma, Ospedale sant'Andrea Recruiting Rome, Italy, 00189 Principal Investigator: Francesco Panzuto, Dr.          Spain Hospital Central de Asturias Recruiting Oviedo, Asturias, Spain Principal Investigator: Paula Jiménez Fonseca, MD          Institut Català d'Oncologia L'Hospitalet Recruiting L'Hospitalet de Llobregat, Barcelona, Spain Principal Investigator: Alexandre Teulé, MD          Hospital Universitario Virgen de la Victoria Recruiting Málaga, Malaga, Spain, 29010 Principal Investigator: Isabel Sevilla, MD          Hospital Alvaro Cunqueiro Recruiting Vigo, Pontevedra, Spain, 36312 Principal Investigator: M. José Villanueva Silva, MD          Complejo Hospitalario Univ A Coruña Recruiting A Coruña, Spain Principal Investigator: Luis antón Aparicio, MD          Sub-Investigator: María Quindós, MD          Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain Principal Investigator: Jaume Capdevila, MD          Hospital Universitario de Burgos Recruiting Burgos, Spain Contact: Guillermo Crespo Herrero, MD          Principal Investigator: Guillermo Crespo Herrero, MD          Hospital Virgen de las Nieves Recruiting Granada, Spain Principal Investigator: Encarnación González Flores, MD          Hospital universitario de Leon Suspended Leon, Spain MD Anderson Cancer Center Recruiting Madrid, Spain, 28033 Principal Investigator: Enrique Grande Pulido, MD          Hospital Clara Campal Suspended Madrid, Spain Hospital Clínico San Carlos Recruiting Madrid, Spain Principal Investigator: Javier Sastre          Hospital Gregorio Marañón Recruiting Madrid, Spain Principal Investigator: Pilar García Alfonso, MD          Hospital Univ La Paz Recruiting Madrid, Spain Principal Investigator: Ana Custodio, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Principal Investigator: Daniel Castellano, MD          Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain Principal Investigator: Teresa Alonso Gordoa, MD          Hospital Univ de Salamanca Recruiting Salamanca, Spain Principal Investigator: Miguel Navarro, MD          Hospital de Donostia Recruiting San Sebastian, Spain Principal Investigator: Adelaida La Casta, MD          Sub-Investigator: Sara Arévalo, MD          Hospital Marqués de Valdecilla Recruiting Santander, Spain Principal Investigator: Carlos López, MD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Principal Investigator: Marta Benavent, MD          Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Principal Investigator: Vega Iranzo, MD          Hospital La Fe Withdrawn Valencia, Spain Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain Contact: Vicente Alonso, M.D.          Principal Investigator: Vicente Alonso, M.D.          United Kingdom Clatterbridge Cancer Centre Suspended Bebington, Wirral, United Kingdom, CH63 4JY Queen Elisabeth Hospital Birmingham Not yet recruiting Birmingham, United Kingdom, B15 2TH Principal Investigator: Tahir Shah, Dr.          Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Principal Investigator: Christine Thirlwell, Prof.          Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, MB204BX Principal Investigator: Juan Valle, Prof. Less <<
NCT02684006 Renal Cell Cancer Phase 3 Active, not recruiting April 30, 2021 -
NCT03291314 Recurrent Glioblastoma (WHO-Gr... More >>ade IV Glioma) Less << Phase 2 Recruiting September 30, 2018 Belgium ... More >> UZ Brussel Recruiting Brussel, Belgium, 1090 Contact: Bart Neyns, Phd,Md    +32 2 477 ext 54 47    bart.neyns@uzbrussel.be    Principal Investigator: Bart Neyns, Phd,Md Less <<
NCT02762513 Squamous Cell Carcinoma of the... More >> Head and Neck Less << PHASE2 COMPLETED 2020-04-09 University of Michigan Compreh... More >>ensive Cancer Center, Ann Arbor, Michigan, 48109, United States Less <<
NCT01273662 Hepatocellular Carcinoma PHASE2 COMPLETED 2025-12-16 National Taiwan University Hos... More >>pital, Taipei City, 100, Taiwan|Taipei Veterans General Hospital, Taipei City, 11217, Taiwan|Tri-Service General Hospital, Taipei City, 114, Taiwan Less <<
NCT01469546 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01140737 Soft Tissue Sarcoma PHASE2 COMPLETED 2019-01-08 Aberdeen Royal Infirmary, Aber... More >>deen, Scotland, United Kingdom|Western General Hospital, Edinburgh, Scotland, United Kingdom|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|St. James's Hospital, Leeds, United Kingdom|Royal Marsden Hospital, London, United Kingdom|Royal Marsden, London, United Kingdom|University College London Hospitals, London, United Kingdom|Christies, Manchester, United Kingdom|Nottingham City Hospital, Nottingham, United Kingdom|Churchill Hospital, Oxford, United Kingdom|Penella Woll, Sheffield, United Kingdom|Southampton General Hospital, Southampton, United Kingdom|Clatterbridge Centre for Oncology, Wirral, United Kingdom Less <<
NCT01469546 - Completed - -
NCT00859118 Neoplasms Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53575 Less <<
NCT01798446 Renal Cell Carcinoma|Nonclear ... More >>Cell|Temsirolimus Resistance Less << PHASE2 COMPLETED 2025-12-16 Seou National University Hospi... More >>tal, Seoul, 110744, Korea, Republic of Less <<
NCT01211275 Malignant Pleural Mesothelioma Phase 1 Phase 2 Completed - Netherlands ... More >> Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, Noord-Holland, Netherlands, 1066 CX Less <<
NCT01558661 - Completed - -
NCT01263769 Kidney Cancer PHASE2 COMPLETED 2023-06-05 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT01599754 Clear Cell Renal Carcinoma Phase 3 Terminated(Primary endpoint di... More >>d not reach statistical significance) Less << - -
NCT02493751 Renal Cell Cancer Phase 1 Active, not recruiting January 22, 2020 United States, Arizona ... More >> Oncology Research Associates, PLLC d/b/a Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, District of Columbia Georgetown University Medical Center Department of Pharmacy, Research Washington, District of Columbia, United States, 20007 Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Massachusetts Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Drug Shipment address: Attn. Alicia Sammarco, RPh,NYU Investigational Pharmacy New York, New York, United States, 10016 Laura & Isaac Perlmutter Cancer Center At NYU Langone New York, New York, United States, 10016 NYU Langone Medical Center New York, New York, United States, 10016 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232-5310 Vanderbilt University Oncology Pharmacy (ship drug only) Nashville, Tennessee, United States, 37232 United States, Utah University of Utah, Huntsman Cancer Hospital Salt Lake City, Utah, United States, 84112 University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Japan Niigata University Medical & Dental Hospital Chuo-ku, Niigata, Niigata, Japan, 951-8520 Kindai University Hospital Osakasayama, Osaka, Japan, 589-8511 Keio University Hospital Shinjuku-ku, Tokyo, Japan, 160-8582 United Kingdom Mount Vernon Cancer Center, East and North Herts. NHS Trust London, Middlesex, United Kingdom, HA6 2RN St Helier Hospital Carshalton, Surrey, United Kingdom, SM5 1AA St. Bartholomew's Hospital London, United Kingdom, EC1A 7BE The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX The Royal Marsden NHS Foundation Trust Sutton, United Kingdom, SM2 5PT Less <<
NCT03341845 Renal Cell Carcinoma Phase 2 Recruiting January 31, 2025 Netherlands ... More >> Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Axel Bex, MD, PhD    0205129111    a.bex@nki.nl Less <<
NCT01533948 Extraocular Extension Melanoma... More >> Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IIIA Intraocular Melanoma Stage IIIA Melanoma Stage IIIB Intraocular Melanoma Stage IIIB Melanoma Stage IIIC Intraocular Melanoma Stage IIIC Melanoma Stage IV Intraocular Melanoma Stage IV Melanoma Less << Phase 2 Terminated(low accrual) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01558661 Adenoid Cystic Carcinoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01533948 - Terminated(low accrual) - -
NCT01806064 Renal Cell Carcinoma Phase 1 Phase 2 Active, not recruiting June 2019 -
NCT01435122 Carcinoid Tumor PHASE2 COMPLETED 2018-02-13 University of California San F... More >>rancisco (UCSF), San Francisco, California, 94115, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States Less <<
NCT02639182 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Active, not recruiting January 2019 -
NCT01435122 Carcinoid Tumor PHASE2 COMPLETED 2018-02-13 University of California San F... More >>rancisco (UCSF), San Francisco, California, 94115, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States Less <<
NCT01334112 Hepatocellular Carcinoma Phase 2 Completed - Canada, Alberta ... More >> Foothills Hospital, Alberta Health Services Calgary, Alberta, Canada Canada, Ontario University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT02859012 Recurrent ACC, metastaticACC, ... More >>Unreaectable ACC Less << Phase 2 Active, not recruiting August 2020 Korea, Republic of ... More >> Department of Internal Medicine, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT03472560 Non-Small Cell Lung Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting September 18, 2020 United States, Arizona ... More >> Arizona Oncology Associates- Saguaro Cancer Center Recruiting Glendale, Arizona, United States, 85308 Arizona Oncology Associates- Biltmore Cancer Center Recruiting Phoenix, Arizona, United States, 85016 Arizona Oncology Associates- Deer Valley Cancer Center Recruiting Phoenix, Arizona, United States, 85027 Arizona Oncology Associates- East Valley Cancer Center Recruiting Tempe, Arizona, United States, 85284 United States, Michigan Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Karmanos Cancer Institute Not yet recruiting Farmington Hills, Michigan, United States, 48334 United States, Missouri Oncology Hematology Associates Recruiting Springfield, Missouri, United States, 65807 United States, Nebraska Oncology Hematology West, PC dba Nebraska Cancer Specialists Recruiting Omaha, Nebraska, United States, 68114 Oncology Hematology West, PC dba Nebraska Cancer Specialists Recruiting Omaha, Nebraska, United States, 68130 United States, Ohio Toledo Clinic Cancer Center- Toledo Not yet recruiting Toledo, Ohio, United States, 43623 United States, South Carolina Saint Francis Hospital Recruiting Greenville, South Carolina, United States, 29601 Saint Francis Hospital Cancer Center Recruiting Greenville, South Carolina, United States, 29607 Hungary Orszagos Onkologiai Intezet Not yet recruiting Budapest, Hungary, H-1122 Pecsi Tudomanyegyetem Klinikai Kozpont Not yet recruiting Pecs, Hungary, H-7624 Tudogyogyintezet Torokbalint Recruiting Torokbalint, Hungary, H-2045 Korea, Republic of National Cancer Center Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of, 10408 Samsung Medical Center Recruiting Gangnam-gu, Seoul, Korea, Republic of, 06351 Asan Medical Center Not yet recruiting Songpa-gu, Seoul, Korea, Republic of, 05505 Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Taiwan Chi Mei Hospital, Liouying Recruiting Tainan City, Liouying District, Taiwan, 73657 National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less <<
NCT02579811 Metastatic Renal Cell Cancer PHASE2 COMPLETED 2023-06-20 City of Hope Comprehensive Can... More >>cer Center, Duarte, California, 91010, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States|The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio, 43210, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States Less <<
NCT02782403 Leukemia Phase 1 Phase 2 Recruiting March 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       pbose@mdanderson.org Less <<
NCT02597322 cT2a N0NxM0 Renal Tumor Phase 2 Completed - France ... More >> Bicêtre Hospital Le Kremlin Bicêtre, France, 94275 Less <<
NCT01693822 Clear-cell Metastatic Renal Ce... More >>ll Carcinoma Less << PHASE2 COMPLETED 2022-02-28 Royal Surrey County Hospital, ... More >>Guildford, Surrey, GU2 7XX, United Kingdom|Royal Marsden Hospital - Sutton, London, Sutton, SM2 5PT, United Kingdom|Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom|Guy's Hospital, London, Se1 9RT, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, United Kingdom Less <<
NCT01562197 Glioblastoma Multiforme Phase 2 Active, not recruiting December 2017 Belgium ... More >> UZ Brussel Brussel, Belgium, 1090 Less <<
NCT02489695 Papillary Renal Cell Carcinoma PHASE2 COMPLETED 2025-07-19 ICO Paul Papin, Angers, 49933,... More >> France|Chu Bordeaux, Bordeaux, 33075, France|Centre Francois Baclesse, Caen, 14076, France|Centre Geogres Fran?ois Leclerc, Dijon, 21079, France|Centre Leon Berard, Lyon, 69373, France|Institut Paoli Calmettes, Marseille, 13273, France|ICO - René Gauducheau, Saint-herblain, 44805, France|Institut Claudius Regaud, Toulouse, 31059, France|ICL, Vandoeuvre-les-nancy, 54519, France|Gustave Roussy, Villejuif, 94805, France Less <<
NCT02261207 Solitary Fibrous Tumor PHASE2 COMPLETED 2025-03-18 Fondazione IRCCS Istituto Naaz... More >>ionale dei Tumori, Milan, MI, 20133, Italy Less <<
NCT02164838 Refractory or Recurrent Solid ... More >>Tumors, Excluding CNS Tumors Less << PHASE1 COMPLETED 2017-10-19 Children's Hospital of Alabama... More >>, Birmingham, Alabama, 35233, United States|Childrens Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Parnassus, San Francisco, California, 94143, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Mark O Hatfield-Warren Grant Magnusun Clinical Center, Bethesda, Maryland, 20892, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48108, United States|University of Minnesota Cancer Center-Fairview, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Columbia University Medical Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98145, United States|Midwest Children's Cancer Center, Milwaukee, Wisconsin, 53226, United States|Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada Less <<
NCT02700568 Carcinoma, Renal Cell ... More >> Clear Cell Renal Cell Carcinoma Less << Phase 2 Recruiting August 2018 Russian Federation ... More >> Demchenkova Marina Viktorovna Recruiting Irkutsk, Russian Federation Semenov Andrey Vladimirovich Recruiting Ivanovo, Russian Federation Mikhailova Nadezhda Vasilievna Recruiting Kazan, Russian Federation Eskerov Kurban Abdulmutalibovich Active, not recruiting Kirov, Russian Federation Zukov Ruslan Aleksandrovich Recruiting Krasnoyarsk, Russian Federation Ovchinnikova Elena Georgievna Recruiting Nizhny Novgorod, Russian Federation Guseva Irina Vasilievna Recruiting Penza, Russian Federation Vladimirova Lyubov Yur'evna Active, not recruiting Rostov-on-Don, Russian Federation Zolotoreva Tatiana Gennadievna Recruiting Samara, Russian Federation Katkov Alexey Aleksandrovich Active, not recruiting Saratov, Russian Federation Ivannikov Andrey Andreyevich Recruiting Tambov, Russian Federation Usynin Evgeny Anatolievich Recruiting Tomsk, Russian Federation Evstegneyeva Irina Vladimirovna Recruiting Tver, Russian Federation Khmelevsky Andrey Anatolievich Recruiting Ufa, Russian Federation Gurina Ludmila Ivanovna Active, not recruiting Vladivostok, Russian Federation Less <<
NCT03592199 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 11, 2022 Brazil ... More >> Instituto do Cancer do Estado de São Paulo Recruiting São Paulo, Brazil, 01246000 Contact: David QB Muniz, MD    +551138932691    david.muniz@hc.fm.usp.br    Contact: Diogo A Bastos, MD    +551138932691    diogo.bastos@hc.fm.usp.br    Principal Investigator: David QB Muniz, MD          Sub-Investigator: Carlos Dzik, MD, PHD          Sub-Investigator: Diogo A Bastos, MD          Sub-Investigator: Jamile A Silva, MD          Sub-Investigator: Pedro HI Velho, MD Less <<
NCT02857712 Salivary Gland Cancers PHASE2 COMPLETED 2025-01-19 Fondazione IRCCS Istituto Nazi... More >>onale dei Tumori, Milan, 20133, Italy Less <<
NCT03494816 Renal Cell Carcinoma ... More >> Metastatic Renal Cell Carcinoma Non-metastatic Renal Cell Carcinoma Less << Phase 2 Recruiting June 1, 2020 United Kingdom ... More >> Addenbrookes Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Ellie Couch          Principal Investigator: Kate Fife          Western General Hospital Recruiting Edinburgh, United Kingdom, EH4 2XU Contact: Susan Forman          Principal Investigator: Steve Leung          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Contact: Maria Nicol          Principal Investigator: Rob Jones          St George's Hospital Not yet recruiting London, United Kingdom, SW17 0QT Contact: Sam Hollingworth          Principal Investigator: Pieter Le Roux          Royal Marsden Recruiting London, United Kingdom, SW3 6JJ Contact: Darshana Shah          Principal Investigator: David Nicol          The Christie Not yet recruiting Manchester, United Kingdom, M20 4BX Contact: Kate Armitage          Principal Investigator: Tom Waddell Less <<
NCT02129647 Neurofibromatosis Type 2|Vesti... More >>bular Schwannomas Less << PHASE2 COMPLETED 2019-02-05 NYU Langone Medical Center, Ne... More >>w York, New York, 10016, United States Less <<
NCT02814461 Advanced Hepatocellular Carcin... More >>oma (HCC) Less << Phase 1 Recruiting November 2018 Taiwan ... More >> Shin Kong Wu Ho-Su Memorial Hospital Recruiting Taipei, Taiwan, 11101 Contact: Kai-Lin Yang, M.D.    +886-28332211 ext 2275    M011360@ms.skh.org.tw Less <<
NCT03438708 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting February 1, 2020 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Candace M Winkler, MS    858-822-5398    cmwinkler@ucsd.edu    Contact: Arlene Araneta    8588226187    aaraneta@ucsd.edu Less <<
NCT03839498 Pheochromocytoma|Paraganglioma PHASE2 UNKNOWN 2025-01-24 Columbia University Irving Med... More >>ical Center, New York, New York, 10031, United States Less <<
NCT05904730 Breast Cancer|Ovarian Cancer|B... More >>reast Neoplasms|Ovarian Neoplasms|BRCA Mutation|HER2-positive Breast Cancer|HER2-negative Breast Cancer|HER-2 Protein Overexpression Less << PHASE1 COMPLETED 2024-12-26 Trials TEAM, Dnipro, 49102, Uk... More >>raine|Trials TEAM, Kyiv, 04107, Ukraine Less <<
NCT04258956 Gastrointestinal Stromal Tumor... More >>s Less << PHASE2 UNKNOWN 2023-04-30 Maria Sklodowska-Curie Nationa... More >>l Research Institue of Oncology, Warsaw, 02-781, Poland Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.94mL

2.59mL

1.29mL

25.88mL

5.17mL

2.59mL

References

 

Historical Records

Categories